stock market investment discussion forums
  Login  |  Register |  Site Map  |  Blogs |  Recent Activity  |  Members  | Glossary
Ticker/Industry
  Joined Today: 5

New Member Registration | Post New Message | Invite Friends | 
Jump to #

View All PLRS Posts | Show Members
PLRS Home PLRS Profile SEC Filings Search Results
#32: StockPro:  Interview with William R. Prather
Sr. VP Corporate Development of Pluristem Life Systems, Inc. William R. Prather's...
April 2, 2007
02:34:21 PM
#31: Stock News Bot:  PLRS News Pluristem Upgrading Its Manufacturing Facility to Support $200 Million in Production Capacity for PLX - I
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell...
March 29, 2007
05:30:00 AM
#30: Stock News Bot:  PLRS News Pluristem Announces Scientific Advance in Stem Cell Research; Evidence That PLX Cells Are Immunosuppressive
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell...
March 1, 2007
04:00:00 AM
#29: Stock News Bot:  PLRS News Pluristem Life Systems, Inc. Announces First Licensing Agreement and Stock Swap With Stem Cell Innovations, Inc.
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS) (Pluristem)...
February 22, 2007
04:00:00 AM
#28: Stock News Bot:  PLRS News Pluristem Announces Private Equity Investment of $8M
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell...
February 14, 2007
04:00:00 AM
#27: Stock News Bot:  PLRS News Pluristem Appoints Dr. William R. Prather as Senior VP of Corporate Development
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell...
January 16, 2007
04:30:00 AM
#26: Stock News Bot:  PLRS News Pluristem Submits Pre-Investigational New Drug Document to FDA
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell...
January 4, 2007
03:00:00 AM
#25: Stock News Bot:  PLRS News Dutton Associates Announces Investment Opinion: Pluristem Life Sciences Speculative Buy Rating in Update Coverage by Dutton Associates
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage...
December 11, 2006
09:15:00 AM
#24: Stock News Bot:  PLRS News Pluristem to Present at Annual Meeting of American Society of Hematology: Breakthrough Method Improves Engraftment of Umbilical Cord Blood in Treating Severe Blood Disorders
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB: PLRS) today...
December 5, 2006
04:30:00 AM
#23: Stock News Bot:  PLRS News Pluristem Appoints Yaky Yanay Chief Financial Officer
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB: PLRS), a cell...
November 1, 2006
04:30:00 AM
#22: Stock News Bot:  PLRS News Pluristem Expects to Submit Pre-IND Document to FDA by End of 2006
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB: PLRS), a cell...
October 31, 2006
04:30:00 AM
#21: Stock News Bot:  PLRS News Dutton Associates Announces Investment Opinion: Pluristem Life Sciences Rating Raised to Speculative Buy by Dutton Associates
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage...
October 25, 2006
06:58:00 AM
#20: Stock News Bot:  PLRS News Pluristem Completes the Conversion to Common Stock of 98% of the $3,000,000 in Convertible Debentures Issued on April 3, 2006
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS)...
October 24, 2006
06:00:00 AM
#19: Stock News Bot:  PLRS News Pluristem Completes Conversion of Outstanding Convertible Debentures
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS) today...
October 24, 2006
04:30:00 AM
#18: Stock News Bot:  PLRS News Pluristem Upgrades Manufacturing Facilities to Enable Production of First Biological Product for Phase I Clinical Trials
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB: PLRS)...
October 18, 2006
04:30:00 AM

 


Tips for using stock message boards discussion forums

Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use.
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.